Product Information(Japanese)
Contact Us
for Business Opportunity
2012.02.14
Summary of Financial Statements for the Fiscal Year Ended December 31, 2011 [Japan GAAP](Non-consolidated)
2011.12.26
SymBio Initiates Japan Phase 2 Trial of Bendamustine HCI(SyB L-0501) in Multiple Myeloma
2011.12.13
Onconova Presents Phase Ⅰ Data for Oral Rigosertib at the 53rd American Society of Hematology Annual Meeting
2011.11.14
Clinical Trial Notification Accepted for SymBio's Japan Phase 2 Trial of Bendamustine HCI(SyB L-0501) in Multiple Myeloma
Product Information(Japanese)
Contact Us